Gonzalez-Ericsson PI, Unni N, Jhaveri K, Stringer-Reasor E, et al. Phase Ib Trial of Fulvestrant, Palbociclib and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer. Clin Cancer Res 2025 Jul 8. doi: 10.1158/1078-0432.CCR-24-3803.
PMID: 40627530